News

Scientists are developing new tests for COVID-19 that are faster and cheaper, and easy to manufacture, so that that they are more available for African countries to purchase.

A new study identifies a method that not only detects SARS-CoV-2 in wastewater samples but also tracks whether the infection rates are trending up or down.

Researchers have come one step closer toward understanding why some people become seriously ill or die from a common bacterium that leaves most people unharmed.

Researchers have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals. This type of test could be used as a check against possible errors generated by the standard tests that directly detect the SARS-CoV-2 virus, the scientists said.

A graphene-based electrochemical biosensor has been developed with an electrical read-out setup to selectively detect the presence of SARS-CoV-2 genetic material in less than five minutes.

In a new study published in the scientific journal Cell, a team from Gladstone, UC Berkeley, and UCSF has outlined the technology for a CRISPR-based test for COVID-19 that uses a smartphone camera to provide accurate results in under 30 minutes.

A novel biomarker can identify patients with an aggressive form of lymphoma unlikely to respond to a targeted treatment called ibrutinib. This finding will help guide physicians toward the right treatment for patients with activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL) who harbor these mutations in the BCL10 gene.

Researchers have now discovered a new form of DNA modification in Zebrafish and the enzyme responsible for this change.

A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. The chip, developed at Imperial College London and known as TriSilix, is a ‘micro laboratory’ which performs a miniature version of the polymerase chain reaction (PCR) on the spot.

Using a new method, Scientists have analyzed tumour samples of Latin American patients suffering from lung cancer, to establish which populations would benefit from further screening.